drugset / Trial / NCT00210912

A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

NCT00210912

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to assess the safety and effectiveness of topiramate as compared to placebo for the prevention of headaches in patients with chronic migraine. Topiramate has been approved to prevent migraine headaches as well as in the treatment of epilepsy.

Timeline

Start
2003-09
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 100 mg Oral

Indications